Search results for "Confidence"

showing 10 items of 1394 documents

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes

2020

Abstract Introduction KRAS mutations are detected in 20% to 30% of NSCLC. However, KRAS mutation subtypes may differently influence the outcome of patients with advanced NSCLC. Methods In the Biomarkers France study, 4894 KRAS mutations (26.2%) were detected in 4634 patients from the 17,664 enrolled patients with NSCLC. Survival and treatment data on noncurative stage III to IV NSCLC were available for 901 patients. First- and second-line treatment effects on progression-free survival and overall survival were analyzed according to the KRAS mutations subtype. Results Over 95% of patients with KRAS mutation were smokers or former smokers who were white (99.5%), presenting with adenocarcinoma…

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyendocrine system diseases[SDV.CAN]Life Sciences [q-bio]/Cancermedicine.disease_causeNSCLClcsh:RC254-28203 medical and health sciences0302 clinical medicine[SDV.CAN] Life Sciences [q-bio]/CancerNon-small cell lung cancerInternal medicinemedicineOverall survivalNon–small cell lung cancerStage (cooking)neoplasms030304 developmental biology0303 health sciencesMutationTransition (genetics)business.industryKRAS mutationmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisConfidence intervaldigestive system diseases3. Good healthrespiratory tract diseasesOncology030220 oncology & carcinogenesisAdenocarcinomaOriginal ArticleKRASbusinessKras mutation
researchProduct

Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?

2021

Background: Saharan dust meets the Canary Islands at the beginning of its westward path across the North Atlantic, exceeding the European daily levels for PM10; for this reason, their two provincial capital cities, constitute optimal sites where to evaluate the health effects of this natural event. Objectives: To assess the short-term association between Saharan Dust Days (SDDs) and respiratory morbidity in the two capital cities. Methods: We carried out a time-series analysis with daily emergency hospital admissions due to all respiratory system diseases, chronic obstructive pulmonary disease (COPD) and asthma between 2001 and 2005, assessing the independent effect of SDDs, defined accordi…

Pulmonary and Respiratory MedicineSeries temporalesRespiratory diseasesSaharan dustProvincial capitalGeneralized additive modelPulmonary diseaseCalima saharianaMineral dustIngresos hospitalariosPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineAir PollutionEnvironmental healthRespiratory morbiditymedicineHumansAfrican air intrusionsRespiratory systemAsthmaHospital admissionsAir PollutantsCOPDbusiness.industryDustGeneral MedicineIntrusiones de aire africanoRespiration Disordersmedicine.diseaseModelos aditivos generalizadosAsthmaConfidence intervalPartículas en suspensiónHospitalizationEnfermedades respiratorias030228 respiratory systemSpainParticulate MatterTime-seriesbusinessParticulate matter
researchProduct

Prediction of mortality rate in acute type A dissection: the German Registry for Acute Type A Aortic Dissection score.

2020

Abstract OBJECTIVES The goal was to develop a scoring system to predict the 30-day mortality rate for patients undergoing surgery for acute type A aortic dissection on the basis of the German Registry for Acute Type A Aortic Dissection (GERAADA) data set and to provide a Web-based application for standard use. METHODS A total of 2537 patients enrolled in GERAADA who underwent surgery between 2006 and 2015 were analysed. Variable selection was performed using the R-package FAMoS. The robustness of the results was confirmed via the bootstrap procedure. The coefficients of the final model were used to calculate the risk score in a Web-based application. RESULTS Age [odds ratio (OR) 1.018, 95% …

Pulmonary and Respiratory Medicinemedicine.medical_specialty030204 cardiovascular system & hematologyPreoperative care03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRisk FactorsMedicineHumansddc:610RegistriesAortic dissectionFramingham Risk Scorebusiness.industryMortality rateDissectionGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalSurgeryCardiac surgeryAortic AneurysmDissectionAortic DissectionTreatment Outcome030228 respiratory systemAcute DiseaseSurgeryCardiology and Cardiovascular MedicinebusinessEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis

2020

Abstract Background The choice of inhaler device for asthma patients depends upon multiple attributes. We investigated factors that may drive general practitioners (GPs) and respiratory specialists in the prescription of inhaler devices for asthma patients who initiated inhalation therapy. Methods We retrospectively analysed prescriptions by GPs and respiratory specialists to asthma patients commencing inhaled corticosteroid/long-acting β2-agonist combination therapy available as both pressurised metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs). Patient characteristics were compared by device and multivariate analysis was used to model the likelihood of receiving a pMDI as oppos…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyMultivariate analysisSettore MED/10 - Malattie Dell'Apparato RespiratorioGeneral practitioner03 medical and health sciencesdry powder inhaler0302 clinical medicineInhalersAdrenal Cortex HormonesAdrenergic beta-2 Receptor AntagonistsAsthma controlGeneral practitionersAdministration InhalationRetrospective analysisMedicine030212 general & internal medicineMetered Dose InhalersMedical prescriptionAsthmaRetrospective Studiesbusiness.industryInhalerdry powder inhalersInhalerOdds ratiomedicine.diseaseConfidence intervalAsthmaPressurised metered-dose inhalerAsthma; dry powder inhalers; General practitioners; Inhalers; Pressurised metered-dose inhalers; Respiratory specialistsPrescriptions030228 respiratory systemRespiratory specialistsInhalationDelayed-Action PreparationsEmergency medicineAdministrationPressurised metered-dose inhalersbusinessAsthma; dry powder inhalers; General practitioners; Inhalers; Pressurised metered-dose inhalers; Respiratory specialists; Administration Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Asthma; Delayed-Action Preparations; Retrospective Studies; Dry Powder Inhalers; Metered Dose Inhalers; Prescriptions
researchProduct

Lung Function Monitoring; A Randomized Agreement Study

2016

Objective: To determine the agreement between devices and repeatability within devices of the forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF) and forced expiratory flow at 50% of FVC (FEF50) values measured using the four spirometers included in the study. Methods: 50 (24 women) participants (20-64 years of age) completed maximum forced expiratory flow manoeuvres and measurements were performed using the following devices: MasterScreen, SensorMedics, Oxycon Pro and SpiroUSB. The order of the instruments tested was randomized and blinded for both the participants and the technicians. Re-testing was conducted on a following day within 72 hours …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVital capacitySpirometersTestingArticleMean difference03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineInternal medicinemedicineAdultsRepeatability030212 general & internal medicineLung functionReproducibilitybusiness.industryMeasurementsRepeatabilityrespiratory systemReproducibilityConfidence intervalrespiratory tract diseases030228 respiratory systemPhysical therapyCardiologybusinessThe Open Respiratory Medicine Journal
researchProduct

Is an activity volume threshold really realistic for lung cancer resection?

2018

IF 1.804 (2017); International audience; Background:We analyzed volume as a continuous variable to estimate threshold, which is a methodology rarely seen in the literature. The objective of this work was to assess hospital volume for lung cancer (LC) surgery and to establish the associated threshold for acceptable in-hospital mortality (IHM). Data was obtained from the French national medico-administrative database.Methods:From January 2005 to December 2016, data from 108,571 patients operated for LC in France were collected from the national administrative database. To estimate the volume threshold, hierarchical logistic regression models were developed.Results:The crude IHM rate was 5.2% …

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/Cancer030204 cardiovascular system & hematologyLung cancer (LC)Logistic regressionOddssurgery03 medical and health scienceshospital volume0302 clinical medicineHospital volumethresholdmedicineLung cancerbusiness.industryin-hospital mortality (IHM)Odds ratiomedicine.diseaseConfidence interval3. Good health030228 respiratory systemCardiothoracic surgeryEmergency medicineOriginal ArticlebusinessVolume (compression)Journal of Thoracic Disease
researchProduct

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with …

2020

Reynold A Panettieri Jr,1 Tobias Welte,2 Kartik V Shenoy,3 Stephanie Korn,4 Margret Jandl,5 Edward M Kerwin,6 Rosa Feijoo,7 Peter Barker,8 Richard F Olsson,9 Ubaldo J Martin8 On behalf of the SOLANA Study Investigators1Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, PA, USA; 2Department of Respiratory Medicine, Member of the German Center of Lung Research, Medizinische Hochschule Hannover, Hannover, Germany; 3Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA; 4Pulmonary Department, Universitätsmedizin Mainz, Langenbeckstr, Mainz, Germany; 5Hamburger Institut Für Th…

Pulmonary and Respiratory Medicinesevere asthmamedicine.medical_specialtybenralizumabPlacebolaw.inventionchemistry.chemical_compoundRandomized controlled triallawInternal medicineClinical endpointJournal of Asthma and AllergyImmunology and AllergyMedicinePlethysmographLung volumesOriginal Researchbusiness.industryBenralizumabanti–IL-5RαConfidence intervalchemistryAsthma Control Questionnairerandomized controlled trialinterleukin-5businesseosinophilicJournal of Asthma and Allergy
researchProduct

Urinary incontinence and quality of life: a systematic review and meta-analysis

2021

AbstractBackgroundUrinary incontinence (UI) and low quality of life (QoL) are two common conditions. Some recent literature proposed that these two entities can be associated. However, no attempt was made to collate this literature. Therefore, the aim of this study was to conduct a systematic review and meta-analysis of existing data to estimate the strength of the association between UI and QoL.MethodsAn electronic search of major databases up to 18th April 2020 was carried out. Meta-analysis of cross-sectional and case–control studies comparing mean values in QoL between patients with UI and controls was performed, reporting random-effects standardized mean differences (SMDs) ± 95% confid…

Quality of lifeAgingmedicine.medical_specialty030232 urology & nephrologyUrinary incontinenceReview Article03 medical and health sciences0302 clinical medicineQuality of lifeMedicineHumans030212 general & internal medicineMeta-analysis; Quality of life; Urinary incontinence; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Quality of Life; Urinary Incontinencebusiness.industryGeriatrics gerontologyMean ageQuality of life Urinary incontinence Meta-analysisConfidence intervalMeta-analysisCross-Sectional StudiesUrinary IncontinenceMeta-analysisCase-Control StudiesPhysical therapyFemaleGeriatrics and Gerontologymedicine.symptombusiness
researchProduct

Search for the Associated Production of the Standard-Model Higgs Boson in the All-Hadronic Channel

2009

We report on a search for the standard-model Higgs boson in pp collisions at s=1.96 TeV using an integrated luminosity of 2.0 fb(-1). We look for production of the Higgs boson decaying to a pair of bottom quarks in association with a vector boson V (W or Z) decaying to quarks, resulting in a four-jet final state. Two of the jets are required to have secondary vertices consistent with B-hadron decays. We set the first 95% confidence level upper limit on the VH production cross section with V(-> qq/qq('))H(-> bb) decay for Higgs boson masses of 100-150 GeV/c(2) using data from run II at the Fermilab Tevatron. For m(H)=120 GeV/c(2), we exclude cross sections larger than 38 times the standard-m…

QuarkParticle physicsStandardsFinal stateFermilab TevatronHiggs bosonTevatronFOS: Physical sciencesGeneral Physics and AstronomyElementary particleddc:500.201 natural sciences114 Physical sciencesStandard ModelVector bosonHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Particle decayTellurium compounds0103 physical sciencesJetsB-hadron decaysHigh energy physics010306 general physicsBosonsBosonStandard-model Higgs bosonsPhysicsIntegrated luminosityHIGGS BOSONModel predictionCross section010308 nuclear & particles physicsPhysicsHigh Energy Physics::PhenomenologyConfidence levelsUpper limits3. Good healthVector bosonProduction cross sectionBottom quarksSecondary verticesHiggs bosonCDFHigh Energy Physics::Experiment
researchProduct

Direct Top-Quark Width Measurement at CDF

2010

7 páginas, 2 figuras, 2 tablas.-- CDF Collaboration: et al.

QuarkTop quarkParticle physicsJet energyAstrophysics::High Energy Astrophysical PhenomenaTevatronGeneral Physics and AstronomyFOS: Physical sciencesElementary particleddc:500.27. Clean energy01 natural sciencesBottom quark114 Physical sciencesHigh Energy Physics - ExperimentStandard ModelHEAVY QUARKS DECAY PHYSICSNuclear physicsPHYSICSHigh Energy Physics - Experiment (hep-ex)In-situ calibrationHeavy quarks0103 physical sciencesHigh energy physics010306 general physicsBosonsBosonPhysicsIntegrated luminosityQuark mass010308 nuclear & particles physicsPhysicsHigh Energy Physics::PhenomenologyConfidence levelsDecayUpper limitsDecay channelsTevatronThe standard modelFermilabHigh Energy Physics::ExperimentHEAVY QUARKSData sampleHEAVY QUARKS; DECAY; PHYSICSDECAYWidth measurementsColliderLepton
researchProduct